Home/Filings/4/0001410384-25-000040
4//SEC Filing

Breeden John E 4

Accession 0001410384-25-000040

CIK 0001410384other

Filed

Mar 5, 7:00 PM ET

Accepted

Mar 6, 4:18 PM ET

Size

7.6 KB

Accession

0001410384-25-000040

Insider Transaction Report

Form 4
Period: 2025-03-04
Breeden John E
EVP, Operations
Transactions
  • Sale

    Common Stock

    2025-03-04$80.89/sh23,157$1,873,170177,302 total
  • Sale

    Common Stock

    2025-03-05$80.46/sh35,306$2,840,721141,996 total
Footnotes (4)
  • [F1]The sale reported on this Form 4 represents an Issuer mandated sale by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units, and it does not represent a discretionary trade by the Reporting Person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.8762 to $81.2473 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The sale reported was effected pursuant to a Rule 10b5-l trading plan adopted by the reporting person on June 10, 2024.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $78.69 to $80.70 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Issuer

Q2 Holdings, Inc.

CIK 0001410384

Entity typeother

Related Parties

1
  • filerCIK 0001597609

Filing Metadata

Form type
4
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 4:18 PM ET
Size
7.6 KB